SCHEMBL19082200

SCHEMBL19082200

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5cc6c7ccccc7sc6c6c5sc5ccc7ccccc7c56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
F9 P00740 2/20 0.33
LIMK1 P53667 1/20 0.33
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
PIM3 Q86V86 2/20 0.33
ALOX5 P09917 1/20 0.33
MAPT P10636 1/20 0.32
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
CYP1A1 P04798 1/20 0.31
CYP1B1 Q16678 1/20 0.31
S1PR4 O95977 2/20 0.31
S1PR5 Q9H228 2/20 0.31
PTPN1 P18031 1/20 0.31
PIM1 P11309 1/20 0.30
PIM2 Q9P1W9 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082100 0.92 TNKS (0.39) TNKSTNKS2F9NQO1NQO2
SCHEMBL17945505 0.90 TNKS (0.39) TNKSTNKS2F9LIMK1PIM3
SCHEMBL19091493 0.88 ALOX5 (0.33) TNKSTNKS2NQO1NQO2ALOX5
SCHEMBL17944615 0.85 ALOX5 (0.37) TNKSTNKS2ALOX5MAPTESR1
SCHEMBL17944189 0.85 ALOX5 (0.37) TNKSTNKS2NQO1NQO2ALOX5
SCHEMBL19109210 0.84 TNKS (0.36) TNKSTNKS2F9LIMK1PIM3
SCHEMBL19081885 0.84 ABCG2 (0.36) TNKSTNKS2LIMK1NQO1NQO2
SCHEMBL17944279 0.83 TNKS (0.41) TNKSTNKS2F9LIMK1PIM3
SCHEMBL19082146 0.83 CYP1A1 (0.40) TNKSTNKS2F9LIMK1NQO1
SCHEMBL19082157 0.83 PTPN1 (0.37) TNKSTNKS2LIMK1NQO1NQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 TNKS 2635/4885TNKS2 2644/4885F9 1203/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 TNKS 2635/4885TNKS2 2644/4885F9 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.